What is the difference between thrombosis and atherosclerosis?
Arterial thrombosis usually affects people whose arteries are clogged with fatty deposits. This is known as atherosclerosis. These deposits cause the arteries to harden and narrow over time and increase the risk of blood clots.
Where do most myocardial infarctions occur?
Often it occurs in the center or left side of the chest and lasts for more than a few minutes.
How do you know if you have a blood clot near your heart?
A blood clot in the heart or lungs could include symptoms such as chest pain, shortness of breath, and upper body discomfort in the arms, back, neck, or jaw, suggesting a heart attack or pulmonary embolism (PE).
Which artery is most commonly involved in myocardial infarction?
The vast majority of MI involves the anterior wall (78%). The most common coronary artery affected is the left anterior descending (LAD) branch.
What is cardiac amyloidosis?
Cardiac amyloidosis occurs when plaques of protein byproduct called amyloid build up in heart muscle, affecting its ability to pump blood. The two kinds most likely to damage the heart are light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR).
Which cardiac biomarkers are used in the assessment of cardiac amyloidosis?
There are two main cardiac biomarkers used in the assessment of cardiac amyloidosis, troponin and N-terminal proBNP. As expected, with cardiac damage and dysfunction, there can be an elevation of these markers in patients with cardiac amyloidosis.
How does secondary amyloidosis affect the heart?
Secondary amyloidosis does not usually affect the heart, however. Only about 5 percent of cardiac amyloidosis is caused by deposits of AA protein. Senile amyloidosis. Senile amyloidosis gets its name from the fact that it is almost always seen in older men, most often in men over 70 years of age.
Is there an AHA Scientific Statement on cardiac amyloidosis 2020?
Circulation 2020;Jun 1: [Epub ahead of print]. The following are key points to remember from this American Heart Association Scientific Statement on Cardiac Amyloidosis: Evolving Diagnosis and Management: